Herbalife (HLF) just put a new capital plan on the table. The board approved a share repurchase program of up to US$250 million over three years, giving management room to buy back stock when it sees value.
Herbalife shares have picked up modest near term momentum, with a 1-day share price return of 2.6% and a 7-day share price return of 2.5%, yet the year-to-date share price return is still down 4.6% even after a 35.3% total shareholder return over the past year. This suggests that investors are reassessing both risk and recovery potential in light of the new buyback plan and the company's push toward a broader wellness platform.
Scan how Herbalife's buyback move compares by reviewing hand-picked consumer and wellness businesses on the 29 high quality undervalued stocks that may also be using capital returns to reshape investor expectations.
Herbalife's new US$250 million buyback can be read two ways. Is the market re-rating the story on sentiment alone, or does the current share price still sit below what the business itself implies?
Most Popular Narrative: 28% Undervalued
Herbalife is trading at $12.23 against a most-followed fair value view of $17. This frames the new $250 million buyback as management acting while the market price still lags that narrative.
The company continues to experience flat to declining volumes in several regions, with only modest improvements in constant currency net sales, indicating that the addressable market for Herbalife's traditional model may be reaching maturity and that top-line revenue growth could remain pressured.
Ongoing reliance on network recruiting and regional distributor growth increases vulnerability to macroeconomic downturns and currency headwinds in emerging markets, which may result in heightened volatility in both revenue and net margins.
See why 9 investors see Herbalife as 28% undervalued .
Result: Fair Value of $17 (UNDERVALUED)
Still, if Herbalife's push into personalized wellness technology gains traction and distributor engagement holds up, those trends could challenge the idea that the shares are undervalued.
Find out about the key risks to this Herbalife narrative .
Next Steps
Mixed on Herbalife after this buyback update and shifting wellness push. Move quickly from headline to evidence by weighing the 3 key rewards and 4 important warning signs .
Looking for more Herbalife investment ideas?
Do not stop at Herbalife alone. Use clear, rules based screeners to uncover fresh ideas that fit your risk profile and goals before the next opportunity moves away.
-
Target resilient compounding potential by focusing on businesses with steady fundamentals and manageable debt profiles through the list of solid balance sheet and fundamentals (23 results) .
-
Hunt for pricing gaps where business quality and valuation may be misaligned by scanning the 16 high quality undiscovered gems .
-
Prioritise capital protection first and upside second by filtering for calmer price swings with the 30 resilient stocks with low risk scores .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HLF .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
